LL-37 is a naturally occurring peptide that plays an important role in the body’s first line of defense. It is part of the innate immune system and is studied for
AOD 9604 is a laboratory-synthesized peptide derived from human growth hormone (hGH) and designed for research into fat metabolism and obesity management. This compound is based on a small section
HGH Fragment 176-191 (HGH Frag) is a synthetic peptide consisting of the final 16 amino acids of the human growth hormone (HGH) molecule. Unlike full-length HGH, this truncated fragment does
5-Amino-1MQ is a small-molecule NNMT inhibitor researched for its potential role in regulating energy balance, metabolic function, and adiposity. While the compound is also available in lyophilized powder form for
AOD 9604 is a laboratory-synthesized peptide derived from human growth hormone (hGH) and designed for research into fat metabolism and obesity management. This compound is based on a small section
Cagrilintide + Semaglutide is a dual-agonist research pairing that targets complementary pathways in appetite control, energy regulation, and metabolic balance. Cagrilintide, a long-acting amylin analogue,
Cagrilintide is a novel, long-acting amylin analogue currently under investigation for its effects on metabolic regulation and appetite control. Its structure features N-terminal lipidation, which enhances stability by binding to
CJC-1295 (No DAC), also known as Modified GRF (1-29) or tetra-substituted GRF (1-29), is a synthetic analogue of growth hormone-releasing hormone (GHRH). This peptide consists of the first 29 amino